Vasodilatory and Metabolic Effects of Glucagon-like Peptide-1 in Periphery Circulation in Patients With and Without Type 2 Diabetes Mellitus

NCT01689051 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Blod Pressure
Glucagon-like Peptide-1
Human Physiology
Blood Flow

Interventions

OTHER: human glucagon-like peptide 1 (7-36)amide
OTHER: human glucagon-like peptide 1 (9-36)amide

Sponsor

University Hospital, Gentofte, Copenhagen

Collaborators

[object Object]